I-Caris 150mg Tablet contains Levamisole 150mg, an anthelmintic and immunomodulatory agent primarily used in the treatment of parasitic worm infections and certain immune-related conditions. Levamisole acts by stimulating the host’s immune response and exhibiting direct antiparasitic activity against nematodes. It is indicated for the management of ascariasis, trichuriasis, and hookworm infections. Additionally, Levamisole has been employed as an adjunct therapy in certain malignancies due to its immunostimulatory properties. The recommended dosage and duration of treatment should be determined by a healthcare professional based on the specific condition and patient factors. I-Caris 150mg Tablet is generally well tolerated; however, adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal cramps, as well as neurological symptoms like dizziness and headache. Rare but serious side effects include agranulocytosis and hypersensitivity reactions, necessitating close monitoring during therapy. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in individuals with known hypersensitivity to Levamisole. Use during pregnancy and lactation should be under strict medical supervision. I-Caris 150mg Tablet should be stored in a cool, dry place away from direct sunlight and out of reach of children.